New heart valve trial aims to reduce leaks in aortic stenosis patients
NCT ID NCT04788888
First seen Apr 17, 2026 · Last updated May 22, 2026 · Updated 5 times
Summary
This study tests a new heart valve (NAVITOR) placed using a tube through a blood vessel (TAVR) in 434 people with severe aortic stenosis. The main goals are to check for valve leakage after 30 days and to see how many people have serious problems like death or disabling stroke within a year. Participants are at intermediate or low risk for open-heart surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYMPTOMATIC SEVERE AORTIC STENOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
AKH Wien
Vienna, Austria
-
Azienda Ospedale Università Padova
Padova, Padua, 35128, Italy
-
CHU Gabriel Montpied
Clermont-Ferrand, France
-
Centro Cardiologico Monzino
Milan, Italy
-
Clinique Pasteur Toulouse
Toulouse, France
-
DHZ München
München, Germany
-
Erasmus MC - Thoraxcenter
Rotterdam, Rotterdam, 3015, Netherlands
-
Fiona Stanley Hospital
Murdoch, Murdoch, WA 6150, Australia
-
HerzZentrum Hirslanden
Zurich, Switzerland
-
Herzzentrum Dresden
Dresden, Germany
-
Herzzentrum Leipzig GmbH
Leipzig, Germany
-
Hopital Haut Leveque
Pessac, France
-
Hospital Clinico Universitario San Carlos
Madrid, Madrid, 28040, Spain
-
Hospital Clínic de Barcelona
Barcelona, Spain
-
Hospital General Universitario Dr. Balmis
Alicante, Spain
-
Hospital Ramón y Cajal
Madrid, Madrid, 28034, Spain
-
Hospital Virgen de Rocio
Seville, Spain
-
Kepler Universitätsklinikum GmbH
Linz, Austria
-
Kerckhoff-Klinik GgmbH
Bad Nauheim, Germany
-
Kings College Hospital
London, United Kingdom
-
Klinikum der Johann Wolfgang Goethe-Universität Frankfurt
Frankfurt, Germany
-
Leeds General Infirmary
Leeds, United Kingdom
-
Macquirie University Hopsital
Ryde, Australia
-
Morriston Hospital
Swansea, Swansea, SA6 6NL, United Kingdom
-
Ospedale San Raffaele - Cardiac
Milan, Italy
-
Pineta Grande Hospital
Castel Volturno, Caserta, 81030, Italy
-
Policlinico San Donato
Milan, Milan, 20097, Italy
-
Prince of Wales Hospital
Sydney, Sydney, NSW 2031, Australia
-
Princess Alexandra Hospital
Woolloongabba, Woolloongabba, QLD 4102,, Australia
-
Rigshospitalet
Copenhagen, Denmark
-
Royal Victoria Hospital
Belfast, United Kingdom
-
Shaare Zedek Medical Center
Jerusalem, Telaviv, 9103012, Israel
-
St. Andrew's Hospital
Adelaide, Australia
-
St. Johannes-Hospital
Dortmund, Germany
-
The Alfred Hospital
Melbourne, Australia
-
UKE Hamburg (Universitatsklinik Eppendorf)
Hamburg, Germany
-
Universitätsmedizin Berlin - Charité Campus Mitte (CCM)
Berlin, Germany
Conditions
Explore the condition pages connected to this study.